Last $0.27 USD
Change Today -0.0001 / -0.04%
Volume 37.9K
CTTC On Other Exchanges
As of 5:20 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

competitive technologies inc (CTTC) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/9/14 - $0.55
52 Week Low
09/29/14 - $0.08
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

competitive technologies inc (CTTC) Related Businessweek News

No Related Businessweek News Found

competitive technologies inc (CTTC) Details

Calmare Therapeutics Incorporated, together with its subsidiary, Vector Vision, Inc., provides patent and technology licensing and commercialization services worldwide. It identifies and commercializes technologies in life sciences, including medical testing, diagnostics, pharmaceuticals, biotechnologies, medical devices, and other medical or biological applications; physical sciences comprising chemical, display, and environmental applications; electronics consisting of communications, semiconductors, Internet related, e-commerce, and consumer electronics applications; and nanotechnologies, including the manipulation of microscopic particles into useful arrangements, and smart or novel materials. The company markets technologies and products through contacts in research and development, legal firms, corporations, seminars, and trade shows. It serves product inventors, manufacturers, and distributors. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.

5 Employees
Last Reported Date: 04/30/14
Founded in 1968

competitive technologies inc (CTTC) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $70.2K
Compensation as of Fiscal Year 2013.

competitive technologies inc (CTTC) Key Developments

Calmare Therapeutics Incorporated Presents at LD Micro Conference, Dec-04-2014 07:30 AM

Calmare Therapeutics Incorporated Presents at LD Micro Conference, Dec-04-2014 07:30 AM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Boulevard, Los Angeles, California, United States.

Calmare Therapeutics Incorporated announced delayed 10-Q filing

On 11/14/2014, Calmare Therapeutics Incorporated announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Calmare Therapeutics Incorporated Reports Earnings Results for the Third Quarter Ended September 30, 2014

Calmare Therapeutics Incorporated reported earnings results for the third quarter ended September 30, 2014. For the period, the company reported revenue from the sale and shipment of the Calmare pain therapy devices for the quarter increased 28% or $110,000 to $400,000 as compared with $290,000 for the quarter ended September 30, 2013. Net loss for the quarter increased to $1,229,000 or $0.05 per basic and diluted share as compared with a net loss of $609,000 or $0.04 per basic and diluted share for the quarter ended September 30, 2013.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CTTC:US $0.27 USD -0.0001

CTTC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CTTC.
View Industry Companies

Industry Analysis


Industry Average

Valuation CTTC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.6x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COMPETITIVE TECHNOLOGIES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at